Efficacy of Oral Medications or Intrauterine Device-Delivered Progestin in Patients with Endometrial Hyperplasia with or without Atypia: A Network Meta-Analysis

Efficacy of Oral Medications or Intrauterine Device-Delivered Progestin in Patients with Endometrial Hyperplasia with or without Atypia: A Network Meta-Analysis

The aim of this systematic review was to evaluate the efficacy of oral medication or intrauterine device-delivered progestins in patients with endometrial hyperplasia (EH) with or without atypia. We systematically examined PubMed, EMBASE, the Cochrane Library, and clinicaltrials.gov to identify stud...

Full description

Bibliographic Details
Main Authors:	Yu-Fei Zhang, Yu Fan, Yi Mu, Jin-Ke Li
Format:	Article
Language:	English
Published:	MDPI AG 2023-04-01
Series:	Journal of Clinical Medicine
Subjects:	endometrial hyperplasia hormonal therapy levonorgestrel-releasing intrauterine system oral progestin network meta-analysis
Online Access:	https://www.mdpi.com/2077-0383/12/8/2980

Similar Items

Levonorgestrel-releasing intrauterine device versus oral progesterone for treatment of simple endometrial hyperplasia without atypia
by: Hatice Kansu-Celik, et al.
Published: (2018-03-01)

Aromatase inhibitor “letrozole” versus progestin “norethisterone” in women with simple endometrial hyperplasia without atypia: A prospective cohort trial
by: M. El-shamy, et al.
Published: (2012-06-01)

Levonorgestrel-releasing intrauterine system (Mirena) in compare to medroxyprogesterone acetate as a therapy for endometrial hyperplasia
by: Fariba Behnamfar, et al.
Published: (2014-01-01)

Patient experiences of conservative treatment for early stage endometrial cancer and endometrial hyperplasia with atypia using levonorgestrel intrauterine device: A qualitative study
by: Montana O'Hara, et al.
Published: (2022-02-01)

Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
by: Mu Lv, et al.
Published: (2022-12-01)

Levonorgestrel intrauterine system versus oral progestin for preventing the recurrence of endometrial polyps after hysteroscopic resection: A meta-analysis of 19 randomized controlled trials
by: Y. Sun, et al.
Published: (2020-12-01)

Metformin versus levonorgestrel-releasing intrauterine system in the management of endometrial hyperplasia: a randomized clinical trial
by: Omima T. Taha, et al.
Published: (2023-08-01)

Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response?
by: Molly Dore, et al.
Published: (2021-05-01)

Weight-loss interventions and levonorgestrel intrauterine system implantation for early-stage endometrial cancer and atypical endometrial hyperplasia to reduce perioperative risk of severely obese patients
by: Roze Isono-Taniguchi, et al.
Published: (2023-01-01)

Non-hormonal therapy of patients with fibrocystic mastopathy in combination with endometrial hyperplasia
by: I. O. Borovikov, et al.
Published: (2022-01-01)

COMBINED HORMONOTHERAPY WITH GNRG ANALOGUE AND INTRAUTERINE LEVONORGESTREL-RELEASING SYSTEM OF ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CARCINOMA: PROSPECTIV PILOT RESEARCH
by: A. I. Pashov, et al.
Published: (2012-05-01)

Endometrial hyperplasia and progesterone resistance: a complex relationship
by: Mekan R. Orazov, et al.
Published: (2023-03-01)

Benefits of Levonorgestrel Intrauterine Device Use vs. Oral or Transdermal Progesterone for Postmenopausal Women Using Estrogen Containing Hormone Therapy
by: Kaylee Clark, et al.
Published: (2019-07-01)

Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer
by: Roya Behrouzi, et al.
Published: (2020-01-01)

Prominent decidualization following progestin treatment for endometrial hyperplasia and carcinoma as a mimic of large residual tumor: A cautionary tale
by: Yang Hu, et al.
Published: (2021-05-01)

Effect and Management of Excess Weight in the Context of Fertility-Sparing Treatments in Patients With Atypical Endometrial Hyperplasia and Endometrial Cancer: Eight-Year Experience of 227 Cases
by: Ying Shan, et al.
Published: (2021-11-01)

Progestin plus metformin improves outcomes in patients with endometrial hyperplasia and early endometrial cancer more than progestin alone: a meta-analysis
by: Fengping Shao, et al.
Published: (2023-06-01)

Immunohistochemical features of cyclooxygenase-2 expression in endometrial hyperplasia without atypia
by: N. Ye. Horban, et al.
Published: (2019-07-01)

Fertility-Sparing Approaches in Atypical Endometrial Hyperplasia and Endometrial Cancer Patients: Current Evidence and Future Directions
by: Nayanar-Adela Contreras, et al.
Published: (2022-02-01)

Comparison of the effectiveness of the levonorgestrel-intrauterine device and oral progestogens on regression of endometrial hyperplasia without atypia
by: Ye Shen, et al.
Published: (2022-12-01)

Characterisation of Levonorgestrel-Resistant Endometrial Cancer Cells
by: Dore M, et al.
Published: (2021-10-01)

Identification of potential models for predicting progestin insensitivity in patients with endometrial atypical hyperplasia and endometrioid endometrial cancer based on ATAC-Seq and RNA-Seq integrated analysis
by: Jia-Li Hu, et al.
Published: (2022-08-01)

MicroRNAs as Predictors of Future Uterine Malignancy in Endometrial Hyperplasia without Atypia
by: Chiao-Yun Lin, et al.
Published: (2022-02-01)

Fertility-Sparing Treatment for Endometrial Cancer or Atypical Endometrial Hyperplasia Patients With Obesity
by: Junyu Chen, et al.
Published: (2022-02-01)

The value of MRI in management of endometrial hyperplasia with atypia
by: Purushothaman Natarajan, et al.
Published: (2020-02-01)

Non-atypical endometrial hyperplasia: risk factors for occult endometrial atypia and malignancy in patients managed with hysterectomy
by: Lee Shi Hui, et al.
Published: (2021-05-01)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
by: Jun Guan, et al.
Published: (2022-10-01)

Levonorgestrel-releasing intrauterine system vs. systemic medication or blank control for women with dysmenorrhea: Systematic review and meta-analysis of randomized controlled trials
by: Jing Wang, et al.
Published: (2022-11-01)

Endometrial ablation plus levonorgestrel releasing intrauterine system versus endometrial ablation alone in women with heavy menstrual bleeding: study protocol of a multicentre randomised controlled trial; MIRA2 trial
by: Tamara J. Oderkerk, et al.
Published: (2022-06-01)

Therapeutic options of endometrial hyperplasia management. Current recommendations and prospective directions of treatment
by: T.F. Tatarchuk, et al.
Published: (2021-09-01)

Effects of progestin contraceptive methods on sexual function in reproductive age women: a meta-analysis
by: Mohammad Ghorbani, et al.
Published: (2021-01-01)

Medical treatment of adenomyosis: a literature review
by: Vitaly B. Tskhay, et al.
Published: (2023-07-01)

Breast Cancer Risk with Progestin Subdermal Implants: A Challenge in Patients Counseling
by: Ghada Mohammed, et al.
Published: (2021-12-01)

Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury
by: Hira Imad Cheema, et al.
Published: (2017-11-01)

Levonorgestrel-Releasing Intrauterine System as a Contraceptive Method in Nulliparous Women: A Systematic Review
by: Magdalena Zgliczynska, et al.
Published: (2020-07-01)

Progestins Related to Progesterone and Testosterone Elicit Divergent Human Endometrial Transcriptomes and Biofunctions
by: Sahar Houshdaran, et al.
Published: (2020-04-01)

Postoperative maintenance levonorgestrel-releasing intrauterine system for symptomatic uterine adenomyoma
by: Ching-Jung Lin, et al.
Published: (2018-02-01)

Insertion of the Mirena Intrauterine System for Treatment of Adenomyosis-Associated Menorrhagia: A Novel Method
by: Fu-Shaing Peng, et al.
Published: (2010-06-01)

Laparoscopic adenomyomectomy combined with levonorgestrel-releasing intrauterine system is effective for long-term management of adenomyosis
by: Jilan Jiang, et al.
Published: (2024-01-01)

Challenging Regimen for Long-Term Conservative Treatment of Endometrial Adenocarcinoma in Young Women: A Case Report and Review of the Literature
by: Prasong Tanmahasamut, et al.
Published: (2010-10-01)